Filing Details

Accession Number:
0001387131-20-005521
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-06-08 16:07:40
Reporting Period:
2020-06-05
Accepted Time:
2020-06-08 16:07:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
25743 Therapeuticsmd Inc. TXMD Pharmaceutical Preparations (2834) 870233535
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1532235 G Robert Finizio 951 Yamato Road, Suite 220
Boca Raton FL 33431
Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-06-05 10,000 $1.16 18,335,964 No 4 P Direct
Common Stock Acquisiton 2020-06-05 20,000 $1.15 18,355,964 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,004,941 Indirect See Footnote
Common Stock 995,059 Indirect See Footnote
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.16 to $1.17, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc., any security holder of TherapeuticsMD, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in Footnote (1) to this Form 4.
  2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.14 to $1.15, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc., any security holder of TherapeuticsMD, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in Footnote (2) to this Form 4.
  3. The reported securities are owned by the reporting person's Grantor-Retained Annuity Trust.
  4. The reported securities are owned by Robert Finizio Revocable Trust.